Primary hyperoxaluria type 1 in Japan (vol 25, pg 297, 2005)

被引：0
|
作者：
Takayama, T
Nagata, M
Ichiyama, A
Ozono, S
机构：
来源：
AMERICAN JOURNAL OF NEPHROLOGY | 2005年 / 25卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：416 / 416
页数：1
相关论文
共 50 条
  • [41] Mutation type dictates primary hyperoxaluria type 1 severity
    Nature Reviews Nephrology, 2014, 10 (9) : 482 - 482
  • [42] Cristalline retinopathy from type 2 primary hyperoxaluria (vol 42, pg e203, 2019)
    Couret, C.
    Mainguy, A.
    Weber, M.
    Lebranchu, P.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2019, 42 (07): : 827 - 827
  • [43] How We Treat Primary Hyperoxaluria Type 1
    Breeggemann, Matthew C.
    Harris, Peter C.
    Lieske, John C.
    Tasian, Gregory E.
    Wood, Kyle D.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (06): : 800 - 802
  • [44] Primary hyperoxaluria type 1: practical and ethical issues
    Cochat, Pierre
    Groothoff, Jaap
    PEDIATRIC NEPHROLOGY, 2013, 28 (12) : 2273 - 2281
  • [45] Primary hyperoxaluria type 1: is genotyping clinically helpful?
    Ernst Leumann
    Bernd Hoppe
    Pediatric Nephrology, 2005, 20 : 555 - 557
  • [46] Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria
    Brooks, Ellen R.
    Hoppe, Bernd
    Milliner, Dawn S.
    Salido, Eduardo
    Rim, John
    Krevitt, Leah M.
    Olson, Julie B.
    Price, Heather E.
    Vural, Gulsah
    Langman, Craig B.
    AMERICAN JOURNAL OF NEPHROLOGY, 2016, 43 (04) : 293 - 303
  • [47] RNA interference treatment in primary hyperoxaluria type 1
    Monteverde, Marta Lidia
    REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2023, 43 (04): : 197 - 198
  • [48] PEDIATRICS Timely diagnosis of primary hyperoxaluria type 1
    Chand, Alejandro Quiroga
    Kaskel, Frederick J.
    NATURE REVIEWS NEPHROLOGY, 2009, 5 (12) : 670 - 671
  • [49] UTILITY ESTIMATES FOR TREATMENT IN PRIMARY HYPEROXALURIA TYPE 1
    de Freitas, H.
    Hubig, L.
    Lombardelli, S.
    Danese, D.
    Lloyd, A.
    VALUE IN HEALTH, 2022, 25 (07) : S544 - S544
  • [50] Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
    Garrelfs, Sander F.
    Frishberg, Yaacov
    Hulton, Sally A.
    Koren, Michael J.
    O'Riordan, William D.
    Cochat, Pierre
    Deschenes, Georges
    Shasha-Lavsky, Hadas
    Saland, Jeffrey M.
    van't Hoff, William G.
    Fuster, Daniel G.
    Magen, Daniella
    Moochhala, Shabbir H.
    Schalk, Gesa
    Simkova, Eva
    Groothoff, Jaap W.
    Sas, David J.
    Meliambro, Kristin A.
    Lu, Jiandong
    Sweetser, Marianne T.
    Garg, Pushkal P.
    Vaishnaw, Akshay K.
    Gansner, John M.
    McGregor, Tracy L.
    Lieske, John C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13): : 1216 - 1226
12345